Product Details for: Fiasp
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous, Subcutaneous
1000UNITS/10ML (100UNITS/ML)
Multi-Dose Vial
351(a)
Fiasp
Rx
002
Injection
Subcutaneous
300UNITS/3ML (100UNITS/ML)
Autoinjector
351(a)
Fiasp
Rx
003
Injection
Subcutaneous
300UNITS/3ML (100UNITS/ML)
Multi-Dose Cartridge
351(a)
Fiasp
Rx
004
Injection
Subcutaneous
160UNITS/1.6ML (100UNITS/ML)
Multi-Dose Cartridge
351(a)
Fiasp
Rx
Proper Name
insulin aspart
insulin aspart
BLA Number
208751
208751
Applicant
Novo Nordisk Inc.
Novo Nordisk Inc.
Original Approval Date
September 29, 2017
September 29, 2017
Date of First Licensure